Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Healthcare Medical Devices
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

Pat Mackin Joins CryoLife Board of Directors

PR Newswire October 22, 2014

CryoLife Announces Release Date and Teleconference Call Details for 2014 Third Quarter Financial Results

PR Newswire October 14, 2014

CryoLife Acquires Distribution Rights and Purchase Option for Genesee BioMedical's PhotoFix(TM) Bovine Pericardial Patch

PR Newswire August 7, 2014

CryoLife to Present at 34th Annual Canaccord Genuity Growth Conference

PR Newswire August 5, 2014

CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014

PR Newswire July 30, 2014

CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million

PR Newswire July 24, 2014

CryoLife Announces Release Date and Teleconference Call Details for 2014 Second Quarter Financial Results

PR Newswire July 15, 2014

CryoLife Appoints Pat Mackin as President and Chief Executive Officer

PR Newswire July 10, 2014

CryoLife Increases Quarterly Cash Dividend Nine Percent for the Second Quarter 2014

PR Newswire May 22, 2014

CryoLife Posts Record First Quarter Revenues of $35.7 Million

PR Newswire April 29, 2014

CryoLife Receives FDA 510(k) Clearance for PerClot® Topical Hemostatic Powder in the U.S.

PR Newswire April 29, 2014

CryoLife Announces Release Date and Teleconference Call Details for 2014 First Quarter Financial Results

PR Newswire April 15, 2014

CryoLife Receives FDA Approval to Begin Clinical Trials for PerClot® in the U.S.

PR Newswire April 2, 2014

CryoLife Acquires Distribution Rights and Purchase Option for ProCol® Vascular Bioprosthesis for Hemodialysis Access

PR Newswire March 27, 2014

CryoLife Continues To Support Customer Education With Third Central Venous Pathology Summit

PR Newswire March 19, 2014

CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million

PR Newswire February 20, 2014

CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014

PR Newswire February 19, 2014

CryoLife to Present at 2014 RBC Capital Markets' Global Healthcare Conference

PR Newswire February 18, 2014

CryoLife Announces Expansion in Asia Pacific Markets

PR Newswire February 18, 2014

CryoLife Announces Release Date and Teleconference Call Details for 2013 Fourth Quarter and Year End Financial Results

PR Newswire February 5, 2014